Progesterone

← Back to Lab Reference Library

Category: Hormones  |  Also known as: P4, Serum Progesterone  |  Sample: Serum; draw on cycle days 20 to 23 (mid-luteal) for most meaningful result in premenopausal women

1. What This Test Measures

Progesterone is a steroid hormone produced primarily by the corpus luteum (the temporary endocrine structure that forms in the ovary after ovulation) during the luteal phase of the menstrual cycle. It is also produced in smaller amounts by the adrenal glands in both sexes and by the placenta during pregnancy.

Progesterone serves as a direct precursor to cortisol, testosterone, and aldosterone in the adrenal steroidogenesis pathway. In the body its roles extend far beyond reproduction:

• Endometrial protection: counterbalances estradiol's proliferative effect on the uterine lining; essential for preventing endometrial hyperplasia
• Sleep promotion: progesterone and its metabolite allopregnanolone are potent positive modulators of GABA-A receptors, the primary inhibitory neurotransmitter system; this produces anxiolytic and sedative effects
• Anxiety reduction: allopregnanolone is the most potent endogenous anxiolytic known; low progesterone is a major driver of premenstrual anxiety and perimenopausal mood instability
• Thyroid function: progesterone sensitizes thyroid receptors and supports T4-to-T3 conversion; low progesterone can contribute to thyroid dysfunction symptoms even when TSH is normal
• Anti-inflammatory: progesterone modulates immune function and reduces inflammatory cytokine production
• Neuroprotection: progesterone supports myelin repair and has demonstrated neuroprotective effects in traumatic brain injury research

2. Why This Test Matters

• Confirms ovulation: a mid-luteal progesterone above 10 ng/mL confirms that ovulation occurred. Values below 5 ng/mL in the luteal phase indicate anovulation or a luteal phase defect. This is the most clinically actionable use of a single progesterone measurement.
• Reveals estrogen dominance: even when absolute estradiol is not elevated, inadequate progesterone production creates a relative estrogen excess that drives PMS, heavy periods, breast tenderness, bloating, and mood instability. The estradiol-to-progesterone ratio is often more clinically informative than either value alone.
• Explains sleep disruption: progesterone is one of the body's primary sleep-promoting compounds. Low progesterone in the premenstrual period (days 24 to 28), perimenopause, and menopause is a primary driver of insomnia and early-morning awakening, symptoms that often respond rapidly to bioidentical progesterone replacement.
• Perimenopausal transition: progesterone is often the first hormone to decline significantly in perimenopause, years before estradiol falls dramatically. This early progesterone loss produces the classic perimenopausal pattern of irregular cycles, heavy periods, PMS, sleep disruption, and anxiety while estradiol is still relatively normal.
• Fertility support: adequate luteal phase progesterone is required for embryo implantation and early pregnancy maintenance. Luteal phase deficiency is a treatable cause of infertility and recurrent early pregnancy loss.
• Men's health: progesterone in men serves as a precursor to testosterone and cortisol, counterbalances estrogen effects, and supports sleep and mood. Low progesterone in men on TRT (where total steroid precursor pools shift) can contribute to estrogen dominance symptoms.

3. Standard Lab Reference Range

Phase / Population	Standard Range	Units
Women, follicular phase (days 1 to 13)	0.1 to 0.9	ng/mL
Women, luteal phase (days 14 to 28)	1.8 to 24.0	ng/mL
Women, postmenopausal	Below 0.2	ng/mL
Men (adult)	0.1 to 1.0	ng/mL
Women, first trimester pregnancy	11.2 to 90.0	ng/mL

The luteal phase range of 1.8 to 24.0 ng/mL is extremely wide. A mid-luteal progesterone of 3 ng/mL is "within range" but indicates poor corpus luteum function and inadequate luteal phase support, which is clinically significant for fertility, cycle quality, and symptom burden.

4. Optimal Functional Medicine Range

Phase / Population	FM Optimal	Clinical Significance
Follicular phase (days 1 to 13)	Below 1 ng/mL	Appropriate; progesterone should be low before ovulation
Mid-luteal (days 20 to 23)	10 to 25 ng/mL	Confirms adequate ovulation and corpus luteum function
Mid-luteal below 10 ng/mL	Suboptimal	Luteal phase defect; PMS, sleep disruption, infertility risk
Mid-luteal below 5 ng/mL	Inadequate	Probable anovulation; investigate cause
Postmenopause on HRT	2 to 20 ng/mL	Depends on delivery route; saliva may be more informative for topical progesterone
Men	0.3 to 1.2 ng/mL	Adequate precursor pool; supports testosterone synthesis and estrogen counterbalance

5. Symptoms Associated With Low Progesterone

6. What Causes Low Progesterone

• Anovulation: no ovulation means no corpus luteum and therefore no progesterone surge; caused by PCOS, stress-induced HPG axis suppression, thyroid dysfunction, hyperprolactinemia, and perimenopause
• Luteal phase defect: ovulation occurs but the corpus luteum produces insufficient progesterone; associated with chronic stress, low body weight, excessive exercise, and subclinical thyroid dysfunction
• Chronic stress and elevated cortisol: cortisol and progesterone share the same precursor (pregnenolone); chronic stress shunts pregnenolone toward cortisol production at the expense of progesterone, a phenomenon called "pregnenolone steal"
• Perimenopause: ovarian follicular reserve declines, producing more anovulatory cycles and less corpus luteum progesterone; often the first measurable hormone to significantly decline
• Hypothyroidism: thyroid hormone is required for normal corpus luteum function and progesterone production; even subclinical hypothyroidism can impair luteal phase progesterone
• Excess prolactin: hyperprolactinemia from pituitary adenoma or medications suppresses the HPG axis and impairs corpus luteum function
• Low cholesterol: all steroid hormones including progesterone require cholesterol as a precursor; very low-fat diets or statin therapy that dramatically lowers cholesterol can impair steroidogenesis

7. How to Improve This Marker

8. Related Lab Tests

9. When Testing Is Recommended

• Mid-luteal phase (days 20 to 23): the only clinically meaningful time to test progesterone in premenopausal women; any other time provides a result that is difficult to interpret
• PMS, premenstrual anxiety, mood instability, or sleep disruption specifically in the second half of the cycle
• Heavy, irregular, or absent menstrual cycles
• Fertility evaluation: confirms ovulation and corpus luteum adequacy
• Recurrent early pregnancy loss: low luteal phase progesterone is a treatable cause
• Perimenopausal women with sleep disruption, anxiety, or irregular cycles
• Monitoring bioidentical progesterone hormone replacement therapy
• Any comprehensive functional medicine hormone panel in women
• Men on TRT with estrogen dominance symptoms or sleep disruption

10. Clinical Perspective

11. Frequently Asked Questions